T1	Age 2 13	42 year-old
T3	Disease_disorder 31 51	lymphocytic leukemia
E1	Disease_disorder:T3 
T4	Detailed_description 23 30	chronic
R1	MODIFY Arg1:T4 Arg2:E1	
T5	Therapeutic_procedure 73 95	bone marrow transplant
E2	Therapeutic_procedure:T5 
T6	Detailed_description 62 72	allogeneic
R2	MODIFY Arg1:T6 Arg2:E2	
T7	Date 99 113	September 2013
E3	Date:T7 
T8	Coreference 119 124	graft
E4	Coreference:T8 
R3	IDENTICAL Arg1:E4 Arg2:E2	
T9	Outcome 2994 2998	died
E5	Outcome:T9 
T10	Date 3006 3016	end of May
E6	Date:T10 
T2	Sex 14 17	man
T11	Detailed_description 129 182	mismatched at a single human leukocyte antigen allele
T12	Medication 229 240	alemtuzumab
E7	Medication:T12 
T13	Detailed_description 199 214	T-cell depleted
#1	AnnotatorNotes T13	technically not a procedure done to the patient, but the transplanted cells
R4	MODIFY Arg1:T11 Arg2:E4	
R5	MODIFY Arg1:T13 Arg2:E4	
R6	MODIFY Arg1:E7 Arg2:T13	
T14	Therapeutic_procedure 245 254	engrafted
E8	Therapeutic_procedure:T14 
T15	Date 258 264	day 12
E9	Date:T15 
T16	Therapeutic_procedure 271 281	transplant
E10	Therapeutic_procedure:T16 
T17	Sign_symptom 305 316	lymphopenia
E11	Sign_symptom:T17 
T18	Detailed_description 294 304	persistent
R7	MODIFY Arg1:T18 Arg2:E11	
T19	Sign_symptom 321 329	diarrhea
E12	Sign_symptom:T19 
T20	Disease_disorder 335 344	norovirus
E13	Disease_disorder:T20 
R8	CAUSE Arg1:E13 Arg2:E12	
R9	CAUSE Arg1:E13 Arg2:E11	
T21	Diagnostic_procedure 360 381	posttransplant course
E14	Diagnostic_procedure:T21 
T22	Lab_value 386 398	unremarkable
E15	Lab_value:T22 
R10	MODIFY Arg1:E15 Arg2:E14	
T23	Date 405 416	mid-October
E16	Date:T23 
T24	Sign_symptom 435 443	tinnitus
E17	Sign_symptom:T24 
T25	Disease_disorder 468 490	sensorineural deafness
E18	Disease_disorder:T25 
A1	TREND E18 INC
T26	Detailed_description 448 467	rapidly progressive
R11	MODIFY Arg1:T26 Arg2:E18	
T27	Sign_symptom 514 526	hearing loss
E19	Sign_symptom:T27 
T29	Lab_value 540 546	>95 dB
E21	Lab_value:T29 
T30	Detailed_description 505 513	subtotal
T28	Detailed_description 527 538	bilaterally
R12	MODIFY Arg1:T28 Arg2:E19	
R13	MODIFY Arg1:T30 Arg2:E19	
R14	MODIFY Arg1:E21 Arg2:E19	
T31	Duration 548 562	over 2–3 weeks
E20	Duration:T31 
T32	Diagnostic_procedure 570 596	magnetic resonance imaging
E22	Diagnostic_procedure:T32 
T33	Biological_structure 564 569	Brain
R15	MODIFY Arg1:T33 Arg2:E22	
T34	Diagnostic_procedure 598 601	MRI
E23	Diagnostic_procedure:T34 
R16	IDENTICAL Arg1:E23 Arg2:E22	
T35	Diagnostic_procedure 628 647	cerebrospinal fluid
E24	Diagnostic_procedure:T35 
T36	Diagnostic_procedure 649 652	CSF
E25	Diagnostic_procedure:T36 
R17	IDENTICAL Arg1:E25 Arg2:E24	
T37	Diagnostic_procedure 689 700	neutrophils
E26	Diagnostic_procedure:T37 
T38	Diagnostic_procedure 709 720	lymphocytes
E27	Diagnostic_procedure:T38 
T39	Lab_value 664 679	4 leukocytes/µL
E28	Lab_value:T39 
R18	MODIFY Arg1:E28 Arg2:E24	
T40	Lab_value 685 688	50%
E29	Lab_value:T40 
T41	Lab_value 705 708	50%
E30	Lab_value:T41 
R19	MODIFY Arg1:E29 Arg2:E26	
R20	MODIFY Arg1:E30 Arg2:E27	
R21	SUB_PROCEDURE Arg1:E26 Arg2:E24	
R22	SUB_PROCEDURE Arg1:E27 Arg2:E24	
T42	Lab_value 722 742	6 red blood cells/µL
E31	Lab_value:T42 
R23	MODIFY Arg1:E31 Arg2:E24	
T43	Diagnostic_procedure 744 751	glucose
E32	Diagnostic_procedure:T43 
T44	Diagnostic_procedure 851 868	oligoclonal bands
E33	Diagnostic_procedure:T44 
T45	Lab_value 840 847	absence
E34	Lab_value:T45 
R24	MODIFY Arg1:E34 Arg2:E33	
T46	Diagnostic_procedure 795 802	protein
E35	Diagnostic_procedure:T46 
T47	Lab_value 752 762	2.4 mmol/L
E36	Lab_value:T47 
T48	Lab_value 803 811	61 mg/dL
E37	Lab_value:T48 
R25	MODIFY Arg1:E37 Arg2:E35	
R26	MODIFY Arg1:E36 Arg2:E32	
R27	SUB_PROCEDURE Arg1:E32 Arg2:E24	
R28	SUB_PROCEDURE Arg1:E35 Arg2:E24	
R29	SUB_PROCEDURE Arg1:E33 Arg2:E24	
T49	Diagnostic_procedure 877 902	polymerase chain reaction
E38	Diagnostic_procedure:T49 
T50	Detailed_description 920 923	CSF
R30	MODIFY Arg1:T50 Arg2:E38	
T51	Detailed_description 871 876	Viral
R31	MODIFY Arg1:T51 Arg2:E38	
#2	AnnotatorNotes T51	testing for viral DNA; the test itself is not viral
T52	Medication 1031 1043	valacyclovir
E39	Medication:T52 
T53	Medication 1060 1071	antibiotics
E40	Medication:T53 
T54	Medication 1096 1110	immunoglobulin
E41	Medication:T54 
T55	Sign_symptom 1185 1192	dyspnea
E42	Sign_symptom:T55 
T56	Sign_symptom 1203 1214	hypotension
E43	Sign_symptom:T56 
T57	Sign_symptom 1216 1222	nausea
E44	Sign_symptom:T57 
T58	Diagnostic_procedure 1248 1255	balance
E45	Diagnostic_procedure:T58 
T59	Lab_value 1228 1247	gradually worsening
E46	Lab_value:T59 
R32	MODIFY Arg1:E46 Arg2:E45	
T60	Disease_disorder 941 952	enterovirus
E47	Disease_disorder:T60 
A2	POLARITY E47 NEG
T61	Disease_disorder 957 968	herpesvirus
E48	Disease_disorder:T61 
A3	POLARITY E48 NEG
T62	Dosage 1077 1083	2 g/kg
R33	MODIFY Arg1:T62 Arg2:E41	
T63	Administration 1084 1095	intravenous
R34	MODIFY Arg1:T63 Arg2:E41	
T64	Medication 1112 1116	IVIG
E49	Medication:T64 
R35	IDENTICAL Arg1:E49 Arg2:E41	
T65	Diagnostic_procedure 1264 1287	neurological assessment
E50	Diagnostic_procedure:T65 
T66	Disease_disorder 1309 1338	vestibulocochlear dysfunction
E51	Disease_disorder:T66 
T67	Detailed_description 1298 1308	persistent
R36	MODIFY Arg1:T67 Arg2:E51	
T68	Date 1339 1352	6 weeks after
E52	Date:T68 
T69	Date 1371 1383	mid-December
E53	Date:T69 
T70	Sign_symptom 1421 1430	withdrawn
E54	Sign_symptom:T70 
T71	Sign_symptom 1432 1441	irritable
E55	Sign_symptom:T71 
T72	Sign_symptom 1462 1470	agitated
E56	Sign_symptom:T72 
T73	Detailed_description 1447 1461	intermittently
R37	MODIFY Arg1:T73 Arg2:E56	
A4	TREND E54 INC
A5	TREND E55 INC
A6	TREND E56 INC
T74	Sign_symptom 1484 1495	lymphopenic
E57	Sign_symptom:T74 
T75	Diagnostic_procedure 1497 1508	lymphocytes
E58	Diagnostic_procedure:T75 
T76	Lab_value 1509 1522	0.54 × 106/μL
E59	Lab_value:T76 
R38	MODIFY Arg1:E59 Arg2:E58	
T77	Diagnostic_procedure 1558 1561	MRI
E60	Diagnostic_procedure:T77 
T78	Biological_structure 1575 1580	brain
T79	Lab_value 1586 1598	unremarkable
E61	Lab_value:T79 
R39	MODIFY Arg1:T78 Arg2:E60	
R40	MODIFY Arg1:E61 Arg2:E60	
T80	Diagnostic_procedure 1625 1648	antineuronal antibodies
E62	Diagnostic_procedure:T80 
T81	Detailed_description 1607 1620	serum testing
R41	MODIFY Arg1:T81 Arg2:E62	
R42	MODIFY Arg1:E61 Arg2:E62	
T82	Diagnostic_procedure 1653 1673	electroencephalogram
E63	Diagnostic_procedure:T82 
T83	Disease_disorder 1696 1710	encephalopathy
E64	Disease_disorder:T83 
T84	Disease_disorder 1744 1749	viral
E65	Disease_disorder:T84 
A7	POLARITY E65 UNCERTAIN
T85	Medication 1799 1814	glucocorticoids
E66	Medication:T85 
T86	Dosage 1789 1798	high-dose
R43	MODIFY Arg1:T86 Arg2:E66	
T87	Medication 1830 1834	IVIG
E67	Medication:T87 
T88	Activity 1854 1860	fluids
E68	Activity:T88 
A8	POLARITY E68 NEG
T89	Activity 1862 1866	food
E69	Activity:T89 
A9	POLARITY E69 NEG
T90	Medication 1872 1882	medication
E70	Medication:T90 
A10	POLARITY E70 NEG
T91	Clinical_event 1892 1900	detained
E71	Clinical_event:T91 
T92	Detailed_description 1911 1931	UK Mental Health Act
R44	MODIFY Arg1:T92 Arg2:E71	
T93	Diagnostic_procedure 1940 1943	MRI
E72	Diagnostic_procedure:T93 
T94	Sign_symptom 2002 2022	signal abnormalities
E73	Sign_symptom:T94 
T95	Detailed_description 1989 2001	nonenhancing
T96	Detailed_description 1984 1987	new
R45	MODIFY Arg1:T95 Arg2:E73	
R46	MODIFY Arg1:T96 Arg2:E73	
T97	Detailed_description 184 188	DQB1
R47	MODIFY Arg1:T97 Arg2:T11	
T98	Detailed_description 221 228	in vivo
R48	MODIFY Arg1:T98 Arg2:E7	
T99	Biological_structure 2026 2038	both thalami
T100	Biological_structure 2043 2051	midbrain
R49	MODIFY Arg1:T99 Arg2:E73	
R50	MODIFY Arg1:T100 Arg2:E73	
T101	Biological_structure 2057 2070	cranial nerve
R51	MODIFY Arg1:T101 Arg2:E73	
T102	Sign_symptom 2100 2111	enhancement
E74	Sign_symptom:T102 
A11	POLARITY E74 NEG
T103	Biological_structure 2090 2099	meningeal
R52	MODIFY Arg1:T103 Arg2:E74	
T104	Date 2126 2150	Near the end of December
E75	Date:T104 
T105	Diagnostic_procedure 2167 2173	biopsy
E76	Diagnostic_procedure:T105 
T106	Biological_structure 2154 2166	frontal lobe
R53	MODIFY Arg1:T106 Arg2:E76	
T107	Diagnostic_procedure 2189 2198	Histology
E77	Diagnostic_procedure:T107 
T108	Sign_symptom 2217 2224	gliosis
E78	Sign_symptom:T108 
T109	Detailed_description 2208 2216	reactive
R54	MODIFY Arg1:T109 Arg2:E78	
T110	Sign_symptom 2237 2249	infiltration
E79	Sign_symptom:T110 
T111	Detailed_description 2229 2236	diffuse
R55	MODIFY Arg1:T111 Arg2:E79	
T112	Detailed_description 2255 2274	CD3+/8+ lymphocytes
R56	MODIFY Arg1:T112 Arg2:E79	
T113	Diagnostic_procedure 2298 2321	microbiological testing
E80	Diagnostic_procedure:T113 
T114	Detailed_description 2329 2342	biopsy tissue
R57	MODIFY Arg1:T114 Arg2:E80	
T115	Lab_value 2374 2382	negative
E81	Lab_value:T115 
T116	Detailed_description 2350 2369	infectious etiology
R58	MODIFY Arg1:T116 Arg2:E80	
R59	MODIFY Arg1:E81 Arg2:E80	
T117	Disease_disorder 2471 2497	neurological deterioration
E82	Disease_disorder:T117 
A12	TREND E82 INC
T118	Diagnostic_procedure 2572 2598	next-generation sequencing
E83	Diagnostic_procedure:T118 
T119	Diagnostic_procedure 2600 2603	NGS
E84	Diagnostic_procedure:T119 
R60	IDENTICAL Arg1:E84 Arg2:E83	
T120	Detailed_description 2560 2571	metagenomic
R61	MODIFY Arg1:T120 Arg2:E83	
T121	Date 2544 2556	January 2014
E85	Date:T121 
T122	Detailed_description 2499 2526	CSF and brain biopsy tissue
R62	MODIFY Arg1:T122 Arg2:E83	
T123	Diagnostic_procedure 2610 2613	NGS
E86	Diagnostic_procedure:T123 
T124	Detailed_description 2630 2642	brain biopsy
R63	MODIFY Arg1:T124 Arg2:E86	
T125	Diagnostic_procedure 2644 2659	genome assembly
E87	Diagnostic_procedure:T125 
R64	SUB_PROCEDURE Arg1:E87 Arg2:E86	
T126	Diagnostic_procedure 2665 2686	in situ hybridization
E88	Diagnostic_procedure:T126 
T127	Disease_disorder 2722 2732	astrovirus
E89	Disease_disorder:T127 
T128	Disease_disorder 2734 2738	AstV
E90	Disease_disorder:T128 
R65	IDENTICAL Arg1:E90 Arg2:E89	
T129	Detailed_description 2708 2721	neuroinvasive
R66	MODIFY Arg1:T129 Arg2:E89	
T130	Medication 2816 2825	ribavirin
E91	Medication:T130 
T131	Medication 2830 2834	IVIG
E92	Medication:T131 
T132	Sign_symptom 2906 2931	minimally conscious state
E93	Sign_symptom:T132 
T133	Medication 2956 2964	sedation
E94	Medication:T133 
A13	POLARITY E94 NEG
T134	Date 2968 2978	March 2014
E95	Date:T134 
T135	Date 3018 3032	4 months after
E96	Date:T135 
T136	Diagnostic_procedure 3037 3040	NGS
E97	Diagnostic_procedure:T136 
T137	Date 3069 3085	7.5 months after
E98	Date:T137 
T138	Sign_symptom 3095 3103	symptoms
E99	Sign_symptom:T138 
R67	BEFORE Arg1:E1 Arg2:E2	
*	OVERLAP E2 E3 E4 E7
R68	BEFORE Arg1:E7 Arg2:E8	
*	OVERLAP E8 E9
R69	AFTER Arg1:E9 Arg2:E10	
R70	BEFORE Arg1:E10 Arg2:E11	
*	OVERLAP E11 E12 E13 E14
R71	BEFORE Arg1:E14 Arg2:E16	
*	OVERLAP E16 E17 E18 E19 E20 E22 E24 E38 E47 E48
R72	BEFORE Arg1:E48 Arg2:E39	
*	OVERLAP E39 E40 E41
R73	BEFORE Arg1:E41 Arg2:E42	
*	OVERLAP E42 E43 E44 E45
T139	Detailed_description 1194 1202	postural
R74	MODIFY Arg1:T139 Arg2:E43	
R75	BEFORE Arg1:E45 Arg2:E50	
*	OVERLAP E50 E51 E52
T140	Sign_symptom 1353 1360	symptom
E100	Sign_symptom:T140 
R76	AFTER Arg1:E52 Arg2:E100	
R77	BEFORE Arg1:E100 Arg2:E53	
*	OVERLAP E53 E54 E55 E56 E57 E58 E60 E62 E63 E64 E65 E66 E67
R78	BEFORE Arg1:E67 Arg2:E68	
*	OVERLAP E68 E69 E70
R79	BEFORE Arg1:E70 Arg2:E71	
*	OVERLAP E71 E72 E73 E74
R80	BEFORE Arg1:E74 Arg2:E75	
*	OVERLAP E75 E76 E77 E78 E79 E80 E82
R81	BEFORE Arg1:E82 Arg2:E85	
*	OVERLAP E85 E83 E86 E88 E89
R82	BEFORE Arg1:E89 Arg2:E91	
*	OVERLAP E91 E92
R83	BEFORE Arg1:E92 Arg2:E93	
*	OVERLAP E93 E94 E95
R84	BEFORE Arg1:E95 Arg2:E5	
*	OVERLAP E5 E6 E96
R85	AFTER Arg1:E96 Arg2:E97	
R86	BEFORE Arg1:E97 Arg2:E98	
R87	AFTER Arg1:E98 Arg2:E99	
